Literature DB >> 23222766

Companies in footrace to deliver RNAi.

Aaron Bouchie.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 23222766     DOI： 10.1038/nbt1212-1154

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  3 in total

1.  Biotech in a blink.

Authors:  Ken Garber
Journal:  Nat Biotechnol       Date:  2010-04       Impact factor: 54.908

2.  RNAi momentum fizzles as pharma shifts priorities.

Authors:  Charles Schmidt
Journal:  Nat Biotechnol       Date:  2011-02       Impact factor: 54.908

3.  Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigens.

Authors:  Frank Wegmann; Kate H Gartlan; Ali M Harandi; Sarah A Brinckmann; Margherita Coccia; William R Hillson; Wai Ling Kok; Suzanne Cole; Ling-Pei Ho; Teresa Lambe; Manoj Puthia; Catharina Svanborg; Erin M Scherer; George Krashias; Adam Williams; Joseph N Blattman; Philip D Greenberg; Richard A Flavell; Amin E Moghaddam; Neil C Sheppard; Quentin J Sattentau
Journal:  Nat Biotechnol       Date:  2012-09       Impact factor: 54.908
  3 in total
  8 in total

1.  Advancing polymeric delivery systems amidst a nucleic acid therapy renaissance.

Authors:  Paul A Burke; Suzie H Pun; Theresa M Reineke
Journal:  ACS Macro Lett       Date:  2013-10-15       Impact factor: 6.903

2.  Alnylam's RNAi therapy targets amyloid disease.

Authors:  Ken Garber
Journal:  Nat Biotechnol       Date:  2015-06       Impact factor: 54.908

3.  Efficient tuning of siRNA dose response by combining mixed polymer nanocarriers with simple kinetic modeling.

Authors:  Chad T Greco; Victoria G Muir; Thomas H Epps; Millicent O Sullivan
Journal:  Acta Biomater       Date:  2017-01-04       Impact factor: 8.947

4.  Predicting Gene Silencing Through the Spatiotemporal Control of siRNA Release from Photo-responsive Polymeric Nanocarriers.

Authors:  Chad T Greco; Thomas H Epps; Millicent O Sullivan
Journal:  J Vis Exp       Date:  2017-07-21       Impact factor: 1.355

Review 5.  Small RNA Modifications: Integral to Function and Disease.

Authors:  Xudong Zhang; Aaron E Cozen; Ying Liu; Qi Chen; Todd M Lowe
Journal:  Trends Mol Med       Date:  2016-11-11       Impact factor: 11.951

6.  Correlating preclinical animal studies and human clinical trials of a multifunctional, polymeric nanoparticle.

Authors:  Scott Eliasof; Douglas Lazarus; Christian G Peters; Roy I Case; Roderic O Cole; Jungyeon Hwang; Thomas Schluep; Joseph Chao; James Lin; Yun Yen; Han Han; Devin T Wiley; Jonathan E Zuckerman; Mark E Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-26       Impact factor: 11.205

Review 7.  Development of small RNA delivery systems for lung cancer therapy.

Authors:  Yu Fujita; Kazuyoshi Kuwano; Takahiro Ochiya
Journal:  Int J Mol Sci       Date:  2015-03-06       Impact factor: 5.923

8.  Minimal-length Synthetic shRNAs Formulated with Lipid Nanoparticles are Potent Inhibitors of Hepatitis C Virus IRES-linked Gene Expression in Mice.

Authors:  Anne Dallas; Heini Ilves; Joshua Shorenstein; Adam Judge; Ryan Spitler; Christopher Contag; Suet Ping Wong; Richard P Harbottle; Ian Maclachlan; Brian H Johnston
Journal:  Mol Ther Nucleic Acids       Date:  2013-09-17       Impact factor: 10.183
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.